Thyroid C-cell Tumors: In rodent scientific tests, semaglutide continues to be revealed to lead to thyroid C-mobile tumors. It's unfamiliar whether this risk applies to human beings, but semaglutide is contraindicated in patients with a private or family record of medullary thyroid carcinoma (MTC) or patients with Numerous Endocrine Neoplasia syndr… Read More